Product Details
Abilify Maintena
Aripiprazole400 mg/Vial
Powder for Prolonged Release Injectable Suspension
Vial Pack
DIN/PIN/NPN
02420872
Manufacturer
Otsuka Pharmaceutical Co. Ltd.
Formulary Listing Date
2015-07-29
Unit Price
487.2002
Amount MOH Pays
487.2002
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Aripiprazole 400 mg/Vial Powder for Prolonged Release Injectable Suspension in Vial: For the maintenance treatment of schizophrenia in patients who are stabilized on oral aripiprazole who have: A history of non-adherence; AND one of the following: a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.
ATC Code
N05AX12